AIP - Atherogenic index of plasma like significant predictor of cardiovascular risk: From research to practice;AIP - Aterogenní index plazmy jako významný prediktor kardiovaskulárního rizika: Od výzkumu do praxe

Vnitrni Lekarstvi

Volumn 52, Issue 1, 2006, Pages 64-71

  Dobiášová, Milada ^a  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

Author keywords

Atherogenic Index of Plasma Log(TG HDL C) ; Cardiovascular disease; Esterification rate of cholesterol in HDL (FER HDL); Lipoprotein particle size

Indexed keywords

ANTIDIABETIC AGENT; APOLIPOPROTEIN B; CHOLESTEROL; CIPROFIBRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; PIOGLITAZONE; TRIACYLGLYCEROL;

ADULT; AGE; ATHEROGENESIS; ATHEROGENIC INDEX OF PLASMA; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; BODY MASS; CALCULATION; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CLINICAL TRIAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; REVIEW; RISK FACTOR; SCORING SYSTEM; SMOKING; WAIST CIRCUMFERENCE;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; HUMANS; PARTICLE SIZE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TRIGLYCERIDES;

EID: 31944448335     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. HDL). Clinical Biochemistry 2001; 34: 583-588.
2. Dobiášová M. Atherogenic index of plasma [Log(triglycerides/HDL/cholesterol]: Theoretical and practical implications. Clin Chem 2004; 50: 113-115.
3. Dobiášová M, Stříbrná J, Sparks DL et al. Cholesterol esterification rates in very low density lipoprotein and low density lipoprotein-depleted plasma: relation to high density lipoprotein subspecies, sex, hyperlipidemia, and coronary artery disease. Arteriosclerosis and Thrombosis 1991; 11: 64-70.
4. Campos H, Genest JJ Jr, Blijlevens E et al. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 1992; 12: 187-195.
5. Coresh J, Kwiterovich PO jr, Smith HH et al. Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res 1993; 34: 1687-1697.
6. Superko RH. Beyond cholesterol reduction. Circulation 1996; 94: 2351-2360.
7. Dobiášová M, Stříbrná J, Pritchard P et al. Cholesterol esterification rate in plasma depleted of very low and low density lipoprotein is controlled by he proportion of HDL2 and HDL3 subclasses: study in hypertensive and normal middle aged and septuagenarian men. J Lipid Res 1992; 33: 1411-1418.
8. Dobiášová M, Frohlich J. Assays of lecithin cholesterol acyltransferase (LCAT). In: Ordovas JM (ed). Methods in molecular biology. Lipoprotein protocols. Totowa: Humana Press 1998: 217-230.
9. Rainwater DL. Electrophoretic separation of LDL and HDL subclasses In: Ordovas JM (ed). Methods in molecular biology. Lipoprotein protocols. Totowa: Humana Press 1998: 137-151.
10. Freedman DS, Otvos JD, Jeyarajah EJ et al. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol 1998; 18: 1046-1053.
11. Dobiášová M, Frohlich J. Measurement of fractional esterification rate of cholesterol in apoB containing lipoproteins depleted plasma: methods and normal values. Physiol Res 1996; 45: 65-73.
12. Rašloví K, Nagyová A, Dobiášová M et al. Effect of ciprofibrate on lipoprotein metabolism and oxidative stress parameters in patients with type 2 diabetes mellitus and atherogenic lipoprotein phenotype. Acta Diabetol 2000, 37: 131-134.
13. Williams PT, Superko HR, Haskell WL et al. Smallest LDL particles are most strongly related to coronary disease progression in men. Arterioscler Thromb Vasc Biol 2003; 23: 314-321.
14. Brown BG, Xue-Qiao Z, Chait A et al. Simvastatin and Niacin, antioxidans vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001; 345: 1583-1592.
15. HDL and AIP to clinical and laboratory parameters in HATS. 75th EAS Congress, Prague, May 2005, Atherosclerosis Supplements 6/1,50.
16. Frohlich J, Dobiášová M. Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography. Clin Chem 2003; 49: 1873-1880.
17. Tan MH, Johns D, Glazer NB. Pioglitazone Reduces Atherogenic Index of Plasma in Patients with Type 2 Diabetes. Clin Chem 2004; 50: 111-115.
18. Plášková M, Cifková R, Škodová Z et ai. A logarithmically transformed ratio of triglyceride/HDL-cholesterol as an indicator of the atherogenic risk in the Czech population. 75th EAS Congress, Prague, May 2005, Atherosclerosis Supplements 6/1,138.
19. HDL) and logarithmically transformed ratio of triglycerides to HDL-cholesterol. Physiol Res 2001; 50: 1-8.
20. Dobiášová M, Frohlich J. Nový aterogenní index plazmy (AIP) odpovídá poměru triglyceridů a HDL-cholesterolu, velikosti částic lipoproteidů a esterifikační rychlosti cholesterolu: změny po léčbě lipanorem. Vnitř Lék 2000; 46: 152-156.